Nanosphere Inc Ebola Test kits rumor


Beiträge: 67
Zugriffe: 14.611 / Heute: 2
Nanosphere kein aktueller Kurs verfügbar
 
rokrockt:

Nanosphere Inc Ebola Test kits rumor

3
13.10.14 11:03
nanosphere, possible hidden ebola play??


even if not ebola, enterovirals are on the rise and the hype will piggyback ebola, NSPH has definitely have tests for enterovirals.. here are latest news reports on enterovirlas: goo.gl/m0JOP1

Tests for Ebola www.livescience.com/48141-how-doctors-test-for-ebola.html

A number of tests can be used to diagnose Ebola within a few days of the onset of symptoms, which can detect the virus's genetic material or the presence of antibodies against the pathogen.
The most accurate of these is likely the polymerase chain reaction (PCR) test, a technique that looks for genetic material from the virus and creates enough copies of it that it can be detected, Hirsch said. "PCR is a really definitive test," Hirsch said. It can pick up very small amounts of the virus.


nanosphere verigene PCR: www.nanosphere.us/technology

Chemistry

Direct Detection of Nucleic Acids
The detection of DNA or RNA targets using nanoparticle probe technology entails:

Automated nucleic acid extraction and PCR amplification (if necessary) from a clinical sample on the Verigene® Processor SP
Automated transfer of eluted nucleic acids into a Verigene Test Cartridge for hybridization
Primary hybridization of target DNA to capture oligonucleotides on a microarray
specific mediator oligonucleotides and gold nanoparticle probes
Signal amplification of hybridized probes via a silver staining process
Automated qualitative analysis of results performed on the Verigene Reader

investorshub.advfn.com/boards/...msg.aspx?message_id=107131061
Antworten

Werbung

Entdecke die beliebtesten ETFs von Amundi

Lyxor Net Zero 2050 S&P World Climate PAB (DR) UCITS ETF Acc
Perf. 12M: +206,18%
Amundi IBEX 35 Doble Apalancado Diario (2x) UCITS ETF Acc
Perf. 12M: +103,50%
Amundi MSCI Greece UCITS ETF Dist
Perf. 12M: +52,19%
Amundi IBEX 35 UCITS ETF Acc
Perf. 12M: +47,37%
Amundi IBEX 35 UCITS ETF Dist
Perf. 12M: +45,06%

rokrockt:

läuft

 
13.10.14 14:10
Antworten
rokrockt:

+31%

 
13.10.14 14:11
Antworten
Cephei:

Vorhin aufgesprungen, mal sehen wies läuft :)

 
13.10.14 14:12
Antworten
rokrockt:

Ich denke jeder sollte Spenden von dem Gewinn

 
13.10.14 14:15
www.aerzte-ohne-grenzen.de/diseases/ebola/...sECFSXKtAodGCwAOw

www.aktion-deutschland-hilft.de/de/...-Io6DjpsECFZTLtAodanEAIg

www.caritas-international.de/...henhilfe/Ebola/ebola%20spenden
Antworten
rokrockt:

wie geil +34,02%

 
13.10.14 14:23
Antworten
rokrockt:

Ihub

 
13.10.14 14:30
NSPH - Have a look at their site, HERE! They have desktop, on demand, infectious disease testing! This is a HIDDEN EBOLA PLAY! These units can be deployed to AIRPORTS worldwide, to test for a wide array of DEADLY diseases! IMO EBOLA testing will be added to these units! This company stands to make BILLION$! And, BY FAR, will be the BIGGEST STOCK GAINER in HISTORY!


investorshub.advfn.com/boards/...msg.aspx?message_id=107128985
Antworten
Cephei:

NEWS von 14.00 Uhr

 
13.10.14 14:49
Globe Newswire
October 13, 2014: 08:00 AM ET

NORTHBROOK, Ill., Oct. 13, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Verigene® Enteric Pathogens Nucleic Acid Test (EP), which now includes additional viral targets, as well as the bacterial and toxigenic targets cleared by FDA earlier this summer.

Verigene EP is a rapid, easy-to-use and cost-effective alternative to traditional stool diagnostics that the Company believes has the potential to deliver clinical, economic and workflow benefits to hospitals and laboratories.

"Rapid diagnostic tests that accurately detect the organisms that cause diarrheal illness have the ability to improve physician decisions regarding patient management," said Paul A. Granato, PhD, D(ABMM), Director of Microbiology and Scientific Director of Clinical Microbiology at Laboratory Alliance, whose laboratory participated in the Verigene EP clinical trial. "In addition to potentially reducing use of unnecessary or inappropriate antibiotics, these tests can help optimize laboratory staff and budgetary resources by reducing the time and costs associated with working up both negative and positive stool specimens."

Verigene EP is Nanosphere's second FDA-cleared test in the area of gastroenteritis, joining the currently marketed Verigene Clostridium difficile Nucleic Acid Test (CDF), which identifies toxigenic C. difficile and differentiates the 027 hypervirulent strain for epidemiological purposes.

"The feedback we've received from the medical community regarding our approach to designing Verigene EP to provide clinically actionable results for common community-acquired gastrointestinal infections has been very encouraging," said Michael McGarrity, Nanosphere's president and chief executive officer. "We anticipate that the addition of Verigene EP to our infectious disease test menu will provide additional value to our customers and patients."

Nanosphere's menu includes five multiplex molecular diagnostic tests performed using the automated, sample-to-result Verigene System that target infections of the bloodstream, respiratory tract and gastrointestinal tract. They include the Verigene Gram-Positive Blood Culture Test (BC-GP), the Verigene Gram-Negative Blood Culture Test (BC-GN), the Verigene Respiratory Virus Plus Test (RV+), Verigene CDF (each of which is FDA-cleared and CE-marked), and now Verigene EP. Nanosphere anticipates CE marking of Verigene EP in early 2015.

About the Verigene® System

The Verigene System uses Nanosphere's core proprietary gold nanoparticle chemistry to offer highly sensitive, highly specific molecular diagnostic results through low-cost multiplexing. The Verigene System rapidly and accurately detects infectious pathogens and drug resistance markers by targeting conserved genetic regions of a bacterium or virus. Currently, the multiplexed Verigene tests target infections of the bloodstream, respiratory tract and gastrointestinal tract. The information gathered from Verigene test results enables clinicians to make informed patient treatment decisions more quickly, which may result in improved patient outcomes, reduced costs, optimized antibiotic therapy and reduced spread of antibiotic resistance.  
Antworten
rokrockt:

läuft super

 
13.10.14 19:41
Antworten
rokrockt:

gleich 1$

 
13.10.14 20:25
Antworten
rokrockt:

ich hoffe waren heute viele dabei

 
13.10.14 20:42
Antworten
rokrockt:

Perf. seit Threadbeginn: +75,21%

 
13.10.14 21:45
keiner dabei??
Antworten
rokrockt:

NSPH geiles Volumen gestern

 
14.10.14 07:48
bin sehr gespannt wie es heute weiter läuft
Antworten
rokrockt:

Geld/Brief 0,955 : 0,984

 
14.10.14 07:54
Antworten
rokrockt:

gestern war erst ausbruch

 
14.10.14 07:56
meistens laufen werte am 2 Tag weiter bei den Amis
Antworten
HiGhLiFE:

nachbörslich aber -20%

 
14.10.14 08:13
in die Knie gegangen. Hier wurden paar vergessen. Die kommt nochmal zurück unter 1$
Antworten
rokrockt:

NSPH DD

 
14.10.14 08:22
investorshub.advfn.com/boards/...msg.aspx?message_id=107165169
Antworten
rokrockt:

NSPH #16

 
14.10.14 08:25
ich tippe eh auch geiles Pre Market

After Hour wurde sehr viel gehandelt  
Antworten
rokrockt:

NSPH

 
14.10.14 08:37
Ich kann mir vorstellen das die Amis den Gap schliessen werden bei 1,35$

und mindestens SMA200 bei 1,62$ küssen

(Verkleinert auf 78%) vergrößern
Nanosphere Inc Ebola Test kits rumor 764420
Antworten
Cephei:

pre auf 0,80$ - bin gespannt :)

 
14.10.14 10:08
Antworten
TrafficBROKER:

Leipzig

 
14.10.14 10:11
(Verkleinert auf 74%) vergrößern
Nanosphere Inc Ebola Test kits rumor 764445
Antworten
rokrockt:

oha

 
14.10.14 10:25
Antworten
HiGhLiFE:

pulver bereit halten

 
14.10.14 10:32
Bei 0,50
Antworten
HiGhLiFE:

steig ich ein

 
14.10.14 10:33
Antworten
aktiengirl:

@highlife,dann ist der Zock gelaufen,

 
14.10.14 10:39
da brauchst du dann auch nicht mehr rein
Antworten
Auf neue Beiträge prüfen
Es gibt keine neuen Beiträge.

Seite: Übersicht Alle 1 2 3 WeiterWeiter

Hot-Stocks-Forum - Gesamtforum - Antwort einfügen - zum ersten Beitrag springen

Neueste Beiträge aus dem Nanosphere Forum

Wertung Antworten Thema Verfasser letzter Verfasser letzter Beitrag
  12 Nanosphere NSPH - einmalige Chance ! Barica Investments Balu4u 25.04.21 13:04
  4 Nanosphere Inc. iwanooze Centimo 24.04.21 23:56
3 66 Nanosphere Inc Ebola Test kits rumor rokrockt iwanooze 24.04.21 23:45

--button_text--